This work is laying the foundation for the discovery of dual inhibitors of SARS-CoV-2 spike/ACE2 fusion and Aurora A kinase, which could eventually be developed into anticancer agents with potential for COVID-19 treatment. The gene discussed is AURKA; the disease is COVID-19.